Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of Clopidogrel-Reference-Cited by-同舟云学术

Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of Clopidogrel

Published:2017-02-09 Issue:6 Volume:101 Page:791-802
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Zhong W-P¹²,Wu H³,Chen J-Y¹²,Li X-X²,Lin H-M³,Zhang B¹²,Zhang Z-W²,Ma D-L¹²,Sun S¹²,Li H-P¹²,Mai L-P²,He G-D²,Wang X-P²,Lei H-P¹²,Zhou H-K⁴⁵,Tang L⁶,Liu S-W⁶,Zhong S-L¹²

Affiliation:

1. Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention; Guangdong Cardiovascular Institute; Guangzhou China

2. Medical Research Center of Guangdong General Hospital; Guangdong Academy of Medical Sciences; Guangzhou China

3. Sun Yat-sen Memorial Hospital; Sun Yat-sen University; Guangzhou Guangdong China

4. Guangzhou Seq-Health Medical Technology Co., Ltd; Guangzhou China

5. Guangzhou Genedenovo Biotechnology Co., Ltd; Guangzhou China

6. Department of Pharmaceutics; School of Pharmaceutical Sciences, Southern Medical University; Guangzhou China

Funder

National Nature Science Foundation of China

Science and Technology Development Projects of Guangdong Province, China

Science and Technology Development Projects of Guangzhou, Guangdong, China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference45 articles.

1. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;Circulation,2014

2. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;Circulation,2013

3. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention;Aradi;Eur. Heart J.,2015

4. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding;Tantry;J. Am. Coll. Cardiol.,2013

5. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the gauging responsiveness with a VerifyNow P2Y12 assay: impact on thrombosis and safety (GRAVITAS) trial;Price;Circulation,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

2. Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting;Thrombosis Research;2024-08

3. The polygenic implication of clopidogrel responsiveness: Insights from platelet reactivity analysis and next-generation sequencing;PLOS ONE;2024-07-11

4. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance;Clinical Epigenetics;2023-12-15

5. Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics;2023-10-02